JP001

· Johnpro Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JP001, covering 2021-05-11 to 2021-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM [Phase 2, Phase 3]